[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo-Reference-Cited by-同舟云学术

[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo

Published:2021-05 Issue: Volume:137 Page:111388
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhao Yuwan,Li Zhuo,Tang Huancheng,Lin Shanhong,Zeng Wenfeng,Ye Dongcai,Zeng Xin,Luo Qiuming,Li Jianwei,Ao Zhixian,Mo Jierong,Chen Lixin,Yang Yiqiu,Huang Yunsheng,Liu Jianjun

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference32 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J. Clin.,2017

2. Screening for prostate cancer;Frankel;Lancet,2003

3. New concept and treatment of androgen-resistant prostate cancer;Oliver;Mod. Urol.,2009

4. Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study;Scher;Lancet,2010

5. Development of a second-generation antiandrogen for treatment of advanced prostate cancer;Tran;Science,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancer;European Journal of Pharmacology;2023-04

2. NO donors as the wonder molecules with therapeutic potential: Recent trends and future perspectives;Coordination Chemistry Reviews;2023-04

3. Determination of the location of the needle entry point based on an improved pruning algorithm;Mathematical Biosciences and Engineering;2022